Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The study objective is to assess Efficacy and safety of Reparixin treatment as compared to placebo (both on top of standard treatment) in adult patients with severe COVID-19 pneumonia.
Epistemonikos ID: 8448b3ea9daaed036e8127acc2184f95134e5d64
First added on: May 08, 2021